Harri Merisaari
Papers
2
Total Citations
43
H-Index
2
About
Harri Merisaari is a leading researcher in the intersection of medical imaging and oncology, with a primary focus on prostate cancer. His work centers on leveraging multiparametric magnetic resonance imaging (mpMRI) to improve the prediction and understanding of aggressive prostate cancer. Merisaari’s major contributions include pioneering the integration of routine clinical mpMRI with genomic classifiers, such as the Decipher score, to predict biochemical recurrence in patients who have undergone prostatectomy. This work, published in 2019 and cited 28 times, demonstrates a novel, non-invasive approach to risk stratification that could guide post-surgical treatment decisions. He has also explored the role of incidental pelvic inflammation in prostate cancer aggressiveness, a 2022 study with 15 citations that links inflammatory markers to clinical outcomes. By bridging radiological findings with genomic and pathological data, Merisaari’s research enhances the precision of prognosis and opens new avenues for understanding tumor biology. His work is highly relevant for clinicians and researchers seeking to refine personalized treatment strategies for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2